Treatment success rate for patients treated for MDR-TB in Norway

Norway: Treatment success rate for patients treated for MDR-TB was 91.0% in 2022. ▲ Rising

Latest (2022)
91.0%
Change on year
up 35.8%
World rank
21st
of 163 countries
All-time high
100.0%
in 2003
All-time low
33.0%
in 2012
Years of data
18
2002–2022

Treatment success rate for patients treated for MDR-TB in Norway, 2002–2022

4060801002002201220222002: 712003: 1002007: 672008: 502009: 632010: 502011: 752012: 332013: 832014: 902015: 1002016: 912017: 892018: 832019: 502020: 1002021: 672022: 91

Source: World Health Organization, Global Health Observatory.

Analysis

Norway recorded 91.0% for treatment success rate for patients treated for mdr-tb in 2022.

Compared with earlier readings it is up 35.8% on the previous year and up 175.8% over ten years.

Over the whole period, treatment success rate for patients treated for mdr-tb in Norway peaked at 100.0% in 2003 and was at its lowest, 33.0%, in 2012.

That places Norway 21st out of 163 countries with data for 2022, putting it in the top quarter.

The long-run direction has been consistently rising across the 18 years of available data.

Treatment success rate for patients treated for MDR-TB in Norway, year by year

Annual values for Treatment success rate for patients treated for MDR-TB (%) in Norway, 2002 to 2022.
Year Value Change
2002 71.0%
2003 100.0% +40.8%
2007 67.0% -33.0%
2008 50.0% -25.4%
2009 63.0% +26.0%
2010 50.0% -20.6%
2011 75.0% +50.0%
2012 33.0% -56.0%
2013 83.0% +151.5%
2014 90.0% +8.4%
2015 100.0% +11.1%
2016 91.0% -9.0%
2017 89.0% -2.2%
2018 83.0% -6.7%
2019 50.0% -39.8%
2020 100.0% +100.0%
2021 67.0% -33.0%
2022 91.0% +35.8%

Averages by decade

DecadeAverage LowestHighest Years
2000s 70.2% 50.0% 100.0% 5
2010s 74.4% 33.0% 100.0% 10
2020s 86.0% 67.0% 100.0% 3

Countries ranked near Norway

  1. 18 Timor-Leste 95.0% compare
  2. 19 South Sudan 94.0% compare
  3. 20 Saudi Arabia 93.0% compare
  4. 21 Bhutan 91.0% compare
  5. 21 Burundi 91.0% compare
  6. 21 Netherlands 91.0% compare

See the full ranking of 175 places →

More health data for Norway

All data for Norway →

Frequently asked questions

What is treatment success rate for patients treated for mdr-tb in Norway?
Treatment success rate for patients treated for mdr-tb in Norway was 91.0% in 2022, according to World Health Organization, Global Health Observatory.
What is the highest treatment success rate for patients treated for mdr-tb recorded in Norway?
The highest recorded value was 100.0% in 2003.
What is the lowest treatment success rate for patients treated for mdr-tb recorded in Norway?
The lowest recorded value was 33.0% in 2012.
How does Norway rank for treatment success rate for patients treated for mdr-tb?
Norway ranks 21st out of 163 countries with data for 2022.
Is treatment success rate for patients treated for mdr-tb rising or falling in Norway?
Over the last ten years it is up 175.8%. The long-run trend across the full record is rising.
Where does this Norway data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Treatment success rate for patients treated for MDR-TB in Norway. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 06 September 2026, from https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/norway/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/treatment-success-rate-for-patients-treated-for-mdr-tb-percent/norway/">Treatment success rate for patients treated for MDR-TB in Norway</a> — Statizoid

About this data

Indicator
Treatment success rate for patients treated for MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
175 places, 2,495 data points, 1999–2022
Last refreshed